150 related articles for article (PubMed ID: 23510878)
1. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations.
Santhosh S; Bhattacharya A; Harisankar CN; Kochhar R; Mittal BR
Clin Nucl Med; 2013 Nov; 38(11):e423-5. PubMed ID: 23510878
[TBL] [Abstract][Full Text] [Related]
2. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
[TBL] [Abstract][Full Text] [Related]
3. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
Nakajo M; Jinnouchi S; Noguchi M; Uozumi K; Tanabe H; Tateno R; Nakajo M
Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
[TBL] [Abstract][Full Text] [Related]
4. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
[TBL] [Abstract][Full Text] [Related]
6. Focal Autoimmune Pancreatitis Mimicking Pancreatic Cancer on FDG PET/CT Imaging.
Zheng L; Xing H; Li F; Huo L
Clin Nucl Med; 2018 Jan; 43(1):57-59. PubMed ID: 29189377
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET/CT findings of autoimmune pancreatitis.
Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings.
Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L
Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832
[TBL] [Abstract][Full Text] [Related]
10.
Zhang J; Jia G; Zuo C; Jia N; Wang H
BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
12. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Sato M; Okumura T; Shioyama Y; Imura J
Ann Nucl Med; 2008 Apr; 22(3):215-9. PubMed ID: 18498037
[TBL] [Abstract][Full Text] [Related]
13. Imaging diagnosis of post-ERCP focal pancreatitis mimicking pancreatic carcinoma by follow-up F-18 FDG PET/CT.
Jeong Yoon S; Lee B; Park CH
Clin Nucl Med; 2011 Jan; 36(1):70-2. PubMed ID: 21157219
[TBL] [Abstract][Full Text] [Related]
14. Utility of FDG PET/CT in IgG4-related systemic disease.
Nakatani K; Nakamoto Y; Togashi K
Clin Radiol; 2012 Apr; 67(4):297-305. PubMed ID: 22119099
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT in autoimmune pancreatitis.
Nanni C; Romagnoli R; Rambaldi I; Caroli P; Matteucci F; Ambrosini V; Re G; Fanti S
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1264-5. PubMed ID: 24562645
[No Abstract] [Full Text] [Related]
16. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S
J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians.
Buscarini E; Frulloni L; De Lisi S; Falconi M; Testoni PA; Zambelli A
Dig Liver Dis; 2010 Feb; 42(2):92-8. PubMed ID: 19805009
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of autoimmune pancreatitis based on serum IgG4 level.
Matsubayashi H; Sawai H; Kimura H; Yamaguchi Y; Tanaka M; Kakushima N; Takizawa K; Kadooka M; Takao T; Hebbar S; Ono H
Dig Liver Dis; 2011 Sep; 43(9):731-5. PubMed ID: 21515099
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.
Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP
Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544
[TBL] [Abstract][Full Text] [Related]
20. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]